These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20452391)

  • 21. Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice.
    Carvalho Rodrigues MA; Silva Faria MC; Santos NA; Gobe GC; dos Santos AC
    Chem Biol Interact; 2013 Oct; 206(1):90-9. PubMed ID: 24012798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure overload: effects of beta-receptor blockade.
    Grimm D; Huber M; Jabusch HC; Shakibaei M; Fredersdorf S; Paul M; Riegger GA; Kromer EP
    J Mol Cell Cardiol; 2001 Mar; 33(3):487-501. PubMed ID: 11181017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of 'Khamira Abresham Hakim Arshad Wala', a unani formulation against doxorubicin-induced cardiotoxicity and nephrotoxicity.
    Nazmi AS; Ahmad SJ; Rashikh A; Akhtar M; Pillai KK; Najmi AK
    Toxicol Mech Methods; 2011 Jan; 21(1):41-7. PubMed ID: 21067281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.
    Xu C; Hu Y; Hou L; Ju J; Li X; Du N; Guan X; Liu Z; Zhang T; Qin W; Shen N; Bilal MU; Lu Y; Zhang Y; Shan H
    J Mol Cell Cardiol; 2014 Oct; 75():111-21. PubMed ID: 25066695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of carvedilol for ischemia/reperfusion-induced oxidative renal injury in rats.
    Hayashi T; Saitou Y; Nose K; Nishioka T; Ishii T; Uemura H
    Transplant Proc; 2008 Sep; 40(7):2139-41. PubMed ID: 18790173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.
    Wang R; Miura T; Harada N; Kametani R; Shibuya M; Fukagawa Y; Kawamura S; Ikeda Y; Hara M; Matsuzaki M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):45-52. PubMed ID: 16611853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
    Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M
    J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.
    Rodriguez-Perez JC; Losada A; Anabitarte A; Cabrera J; Llobet J; Palop L; Plaza C
    J Pharmacol Exp Ther; 1997 Oct; 283(1):336-44. PubMed ID: 9336341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats.
    Saad SY; Najjar TA; Arafah MM
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):412-7. PubMed ID: 17169121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
    Oliveira PJ; Bjork JA; Santos MS; Leino RL; Froberg MK; Moreno AJ; Wallace KB
    Toxicol Appl Pharmacol; 2004 Oct; 200(2):159-68. PubMed ID: 15476868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress.
    Hayashi T; De Velasco MA; Saitou Y; Nose K; Nishioka T; Ishii T; Uemura H
    Int J Urol; 2010 Dec; 17(12):989-95. PubMed ID: 20946473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorating effect of DL-α-lipoic acid against cisplatin-induced nephrotoxicity and cardiotoxicity in experimental animals.
    Hussein A; Ahmed AA; Shouman SA; Sharawy S
    Drug Discov Ther; 2012 Jun; 6(3):147-56. PubMed ID: 22890205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotective role of H₃R agonist imetit on isoproterenol-induced hemodynamic changes and oxidative stress in rats.
    Yadav CH; Najmi AK; Akhtar M; Khanam R
    Toxicol Mech Methods; 2015; 25(4):235-40. PubMed ID: 25496245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.
    Dziegiel P; Jethon Z; Suder E; Sopel M; Rabczyński J; Surowiak P; Zabel M
    Exp Toxicol Pathol; 2002 Feb; 53(6):433-9. PubMed ID: 11926284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin).
    Machado V; Cabral A; Monteiro P; Gonçalves L; Providência LA
    Rev Port Cardiol; 2008 Oct; 27(10):1277-96. PubMed ID: 19178029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protective effect of eugenol against gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
    Said MM
    Fundam Clin Pharmacol; 2011 Dec; 25(6):708-16. PubMed ID: 21105912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
    Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
    Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.